2008 to 2020 Saw Increase in Survival for Advanced Prostate Cancer
THURSDAY, Oct. 19, 2023 (HealthDay News) — During a time period with improvements in treatment of advanced prostate cancer, there was a simultaneous clinically meaningful increase in mean survival for men with de novo metastatic castration-sensitive …
Learn MoreEnzalutamide + Leuprolide Top for Mets-Free Survival in Prostate Cancer
WEDNESDAY, Oct. 18, 2023 (HealthDay News) — For patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus leuprolide is best for metastasis-free survival, according to a study published in the Oct. 19 issue of the New Eng…
Learn MoreASTRO: Shorter Radiation Feasible for Low-, Intermediate-Risk Prostate Cancer
MONDAY, Oct. 16, 2023 (HealthDay News) — At five years, five-fraction stereotactic body radiotherapy (SBRT) is noninferior to control radiotherapy for biochemical/clinical failure (BCF) in men with localized prostate cancer (LPCa), according to a stu…
Learn MoreSurvival Varies by Race, Ethnicity for Nonmetastatic Castration-Resistant Prostate Cancer
MONDAY, Oct. 16, 2023 (HealthDay News) — Differences in outcomes by race and ethnicity exist for men with nonmetastatic castration-resistant prostate cancer (nmCRPC); however, equal access to care appears to lessen these disparities, according to a s…
Learn MoreCuando el acceso a la atención médica es igual, la brecha racial en la supervivencia del cáncer de próstata desaparece
VIERNES, 13 de octubre de 2023 (HealthDay News) — A los hombres de todas las razas y grupos étnicos que tienen cáncer de próstata les va igual de bien cuando el acceso a la atención es idéntico, según un nuevo estudio.La disparidad en los resultados …
Learn MoreWhen Health Care Access Is Equal, Race Gap in Prostate Cancer Survival Vanishes
THURSDAY, Oct. 12, 2023 (HealthDay News) — Men of all races and ethnic groups who have prostate cancer fare equally well when access to care is identical, a new study finds. The disparity in outcomes from prostate cancer between Black, Hispanic and w…
Learn MoreShorter Courses of Radiotherapy Increasingly Used for Prostate Cancer
TUESDAY, Oct. 10, 2023 (HealthDay News) — From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses (hypofractionation) for prostate cancer, according to a brief report published online Oct. 5 in JAMA Oncology.James B. …
Learn MoreUn experto responde tus preguntas sobre el cáncer de próstata
MARTES, 5 de septiembre de 2023 (Noticias HealthDay) — Es fundamental que los hombres estén familiarizados con las señales de advertencia del cáncer de próstata y se sometan a exámenes, ya que es la segunda causa principal de muerte por cáncer en hom…
Learn MoreAn Expert Answers Your Questions About Prostate Cancer
TUESDAY, Sept. 5, 2023 (HealthDay News) — It’s important for men to be familiar with the warning signs of prostate cancer and get screened because it’s the second-leading cause of cancer death in men, an expert says. While there will be more than 288…
Learn MoreProstate-Specific Antigen Levels Posttreatment May Not Predict Overall Survival
THURSDAY, Aug. 31, 2023 (HealthDay News) — Treatments that reduce the risk for biochemical recurrence (BCR) based on rising prostate-specific antigen levels after radiotherapy do not necessarily improve a patient’s long-term overall survival (OS), ac…
Learn More